title: Rhabdomyolysis and renal failure associated with cerivastatin-gemfibrozil combination therapy.
authors: Mid-America Heart Institute of St. Luke's Hospital, Kansas City, Missouri, USA.
authors: G W
authors: GW
authors: Pogson
authors: L H
authors: LH
authors: Kindred
authors: B G
authors: BG
authors: Carper
mesh_terms: D000368:Aged; D004347:Drug Interactions; D004359:Drug Therapy, Combination; D005260:Female; D015248:Gemfibrozil / Q000008:administration & dosage / Q000009:adverse effects*; D006801:Humans; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors / Q000008:administration & dosage / Q000009:adverse effects*; D000960:Hypolipidemic Agents / Q000008:administration & dosage / Q000009:adverse effects*; D011725:Pyridines / Q000008:administration & dosage / Q000009:adverse effects*; D051437:Renal Insufficiency / Q000139:chemically induced*; D012206:Rhabdomyolysis / Q000139:chemically induced*
chemical_list: D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors; D000960:Hypolipidemic Agents; D011725:Pyridines; C086276:cerivastatin; D015248:Gemfibrozil